287 related articles for article (PubMed ID: 28626480)
1. Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles.
Varshosaz J; Taymouri S; Hamishehkar H; Vatankhah R; Yaghubi S
Res Pharm Sci; 2017 Jun; 12(3):222-232. PubMed ID: 28626480
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.
Sinsuebpol C; Chatchawalsaisin J; Kulvanich P
Drug Des Devel Ther; 2013; 7():861-73. PubMed ID: 24039397
[TBL] [Abstract][Full Text] [Related]
3. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
[TBL] [Abstract][Full Text] [Related]
4. Formulation and optimization of celecoxib-loaded PLGA nanoparticles by the Taguchi design and their in vitro cytotoxicity for lung cancer therapy.
Emami J; Pourmashhadi A; Sadeghi H; Varshosaz J; Hamishehkar H
Pharm Dev Technol; 2015 Nov; 20(7):791-800. PubMed ID: 24841045
[TBL] [Abstract][Full Text] [Related]
5. Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery.
Rattanupatam T; Srichana T
Drug Deliv; 2014 Sep; 21(6):397-405. PubMed ID: 24401124
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
Devrim B; Bozkır A; Canefe K
Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
[TBL] [Abstract][Full Text] [Related]
7. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
Wang Y; Kho K; Cheow WS; Hadinoto K
Int J Pharm; 2012 Mar; 424(1-2):98-106. PubMed ID: 22226876
[TBL] [Abstract][Full Text] [Related]
8. Effect of Solvents, Stabilizers and the Concentration of Stabilizers on the Physical Properties of Poly(d,l-lactide-
Alkholief M; Kalam MA; Anwer MK; Alshamsan A
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456705
[TBL] [Abstract][Full Text] [Related]
9. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary delivery of Nanocomposite Microparticles (NCMPs) incorporating miR-146a for treatment of COPD.
Mohamed A; Pekoz AY; Ross K; Hutcheon GA; Saleem IY
Int J Pharm; 2019 Oct; 569():118524. PubMed ID: 31319144
[TBL] [Abstract][Full Text] [Related]
12. Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate.
Shiehzadeh F; Tafaghodi M; Dehghani ML; Mashhoori F; Fazly Bazzaz BS; Imenshahidi M
Adv Pharm Bull; 2019 Jun; 9(2):255-261. PubMed ID: 31380251
[No Abstract] [Full Text] [Related]
13. Formulation and evaluation of inhaled Sildenafil-loaded PLGA microparticles for treatment of pulmonary arterial hypertension (PAH): A novel high drug loaded formulation and scalable process via hot melt extrusion technology (Part Ⅰ).
Almutairi M; Hefnawy A; Almotairy A; Alobaida A; Alyahya M; Althobaiti A; Adel Ali Youssef A; Elkanayati RM; Ashour EA; Smyth HDC; Repka MA
Int J Pharm; 2024 Apr; 655():124044. PubMed ID: 38527563
[TBL] [Abstract][Full Text] [Related]
14. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.
Sham JO; Zhang Y; Finlay WH; Roa WH; Löbenberg R
Int J Pharm; 2004 Jan; 269(2):457-67. PubMed ID: 14706257
[TBL] [Abstract][Full Text] [Related]
15. Preparation of Poly-Lactic-Co-Glycolic Acid Nanoparticles in a Dry Powder Formulation for Pulmonary Antigen Delivery.
Scherließ R; Janke J
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452155
[TBL] [Abstract][Full Text] [Related]
16. Customizable resveratrol spray-dried micro-composites for inhalation as a promising contender for treatment of idiopathic pulmonary fibrosis.
Ahmed S; Mansour M; Ishak RAH; Mortada ND
Int J Pharm; 2023 Jul; 642():123117. PubMed ID: 37315636
[TBL] [Abstract][Full Text] [Related]
17. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
[TBL] [Abstract][Full Text] [Related]
19. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
20. Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation.
Kunda NK; Alfagih IM; Dennison SR; Tawfeek HM; Somavarapu S; Hutcheon GA; Saleem IY
Pharm Res; 2015 Apr; 32(4):1341-53. PubMed ID: 25297713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
